$AAC Huge upside potential on Short Squeeze.

NYSE:AAC   Ares Acquisition Corporation
Today NYSE:AAC made a announcement that pleased investors very much, but despite this, the stock did not rally as it should have due to poor market conditions. The next few days we could get an almighty short squeeze as 28% of the short is sold short.

Average Analysts Target Price $4.50
Average Recommendation Overweight

Addiction Labs specializes in pharmacogenetics and already offers testing on more than 150 prescribed medications, mostly in the mental health arena. This information helps doctors prescribe personalized medicine for those with substance use disorder and co-occurring mental health conditions, ultimately improving patient outcomes. The cannabis testing would be the first time the lab has investigated the pharmacogenetics of a formerly illicit drug.
AAC Holdings, Inc. engages in the operation rehabilitation centers. The company focuses on the provision of substance abuse and behavioral healthcare treatment services. It offers detoxification, inpatient treatment, partial hospitalization, and intensive outpatient care.

Do you want to GAIN an Edge on Wall Street? 🤑💰📈

1) Sign Up for Free @

2) Follow our Telegram Channel @

3) Join our LIVE CHAT on our Discord @

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.